News

As people across country cope with aftermath of shooting that killed two children during a Catholic Mass, MUSC-based center is helping with recovery.

MUSC Hollings Cancer Center researchers are working on a new drug that destroys cancer cells' energy factories.

New trial to test whether quit-smoking medication works to help people to quit vaping.

MUSC students receive world-class training and make worldwide connections at an international redox training program in Hungary.

MUSC student Thomas Blouin will use an NCI fellowship to study how a chemical that doesn't seem to change DNA still causes cancer.

MUSC researchers have engineered a new type of genetically modified immune cell that could help organ transplant patients who are prone to rejection.

Many people remain unaware that HPV can cause six types of cancer – and that can affect whether people choose to vaccinate.

Counties with historically lower rates of screening for cervical cancer have higher rates of late-stage diagnosis and death.

An MUSC study lays the scientific groundwork for a new approach to preventing compromised kidney function and kidney failure in patients with lupus.

Details in medical record notes are often critical to proper care. AI can help highlight those notes as patients move among doctors in different specialties.